(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Figure out how to Consolidate All encompassing Practices with a Degree in Brain research - 2The biggest black hole breakthroughs of 2025
- 35 Language Learning Applications
- 4A Lone Wolf Outsmarted Hunters in the Black Forest and Then Vanished
- 5Figurine of a woman and a goose offers peek at prehistoric beliefs
- Qatar, Ireland accuse Israel of using chemical weapons on Palestinians, demand watchdog probe use
- Europe pledges over €15bn for clean energy for Africa
- Hoist Your Style: Famous Hairdos for Ladies
- A red meat allergy from tick bites is spreading – and the lone star tick isn’t the only alpha-gal carrier to worry about
- ‘I love this work, but it’s killing me’: The unique toll of being a spiritual leader today
- Luigi Mangione‘s lawyers say Bondi’s death penalty decision was tainted by conflict of interest
- Kelsey Grammer on having a new baby at 70: 'You're just more available now'
- Nurturing Hacks: Astuteness from Experienced Mothers and Fathers
- Malaysian broadcaster rejects altered graphic about electricity rate hike
